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Photoreceptor rod outer segment membrane guanylate cyclase (ROS-GC) is central to
visual transduction; it generates cyclic GMP, the second messenger of the photon
signal. Photoexcited rhodopsin initiates a biochemical cascade that leads to a drop in
the intracellular level of cyclic GMP and closure of cyclic nucleotide gated ion channels.
Recovery of the photoresponse requires resynthesis of cyclic GMP, typically by a pair
of ROS-GCs, 1 and 2. In rods, ROS-GCs exist as complexes with guanylate cyclase
activating proteins (GCAPs), which are Ca2+-sensing elements. There is a light-induced
fall in intracellular Ca2+. As Ca2+ dissociates from GCAPs in the 20–200 nM range, ROS-
GC activity rises to quicken the photoresponse recovery. GCAPs then progressively turn
down ROS-GC activity as Ca2+ and cyclic GMP levels return to baseline. To date, GCAPs
mediate the only knownmechanism of ROS-GC regulation in the photoreceptors. However,
in mammalian cone outer segments, cone synapses and ON bipolar cells, another Ca2+
sensor protein, S100B, complexeswith ROS-GC1 and senses the Ca2+ signal with a K1/2 of
400 nM. Unlike GCAPs, S100B stimulates ROS-GC activity when Ca2+ is bound.Thus, the
ROS-GC system in cones functions as a Ca2+ bimodal switch; with rising intracellular Ca2+,
its activity is ﬁrst turned down by GCAPs and then turned up by S100B. This presentation
provides a historical perspective on the role of S100B in the photoreceptors, offers a pictorial
model for the “bimodal” operation of the ROS-GC switch and projects future tasks that
are needed to understand its operation. Some accounts of this review have been adopted
from the original publications of these authors.
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INTRODUCTION
A seminal observation in the ﬁeld of visual transduction was that
a soluble bovine rod outer segment (ROS) fraction kicked the cat-
alytic activity of a photoreceptor guanylate cyclase into high gear in
the absence of Ca2+ (Koch and Stryer, 1988). The structure of this
guanylate cyclase was believed to be composed of “separate regu-
latory and catalytic subunits” (Stryer, 1991); however, elucidating
the molecular identity of the guanylate cyclase and its regulator
turned out to be quite complicated. Therewere reports that guany-
late cyclase possessed a molecular mass of 67 kDa and was nitric
oxide sensitive (Horio and Murad, 1991a,b). Yet another report
claimed to have solved the molecular structure of the photore-
ceptor retGC, the human retinal guanylate cyclase (Shyjan et al.,
1992).
Later, the true photoreceptor ROS-guanylate cyclase (ROS-
GC) was puriﬁed directly from bovine outer segments (Margulis
et al., 1993) and its protein-sequence-based molecular cloning,
structure, and function were established (Goraczniak et al., 1994).
ROS-GC had a calculated molecular mass of 120,360 Da, a value
similar to 112,000 Da reported earlier for a bovine (Koch, 1991)
and 110,000–115,000 Da for toad photoreceptor guanylate cyclase
(Hayashi andYamazaki, 1991). Unlike the other knownmembrane
guanylate cyclases, atrial natriuretic factor receptor guanylate
cyclase (ANF-RGC; Paul et al., 1987; Sharma, 1988; Chinkers et al.,
1989; Duda et al., 1991) and type C natriuretic peptide CNP-RGC
guanylate cyclase (Koller et al., 1991; Duda et al., 1993), ROS-GC
was not hormonally responsive (Goraczniak et al., 1994). It thus
represented a new subfamily of the membrane guanylate cyclases.
Further study revealed that ROS-GC was not composed of “sep-
arate regulatory and catalytic subunits”, it was not nitric oxide
sensitive nor was its structure identical to retGC. The RetGC
structure was eventually revised to match that of bovine ROS-GC
(Accession number M92432).
Meanwhile, groups from the U.S. and the former Soviet Union
joined forces to describe a newly puriﬁed Ca2+ binding pro-
tein, recoverin, that appeared to regulate guanylate cyclase activity
(Dizhoor et al., 1991) and adhere to the functional description of
Koch and Stryer (Koch and Stryer, 1988). It was therefore con-
sidered a Ca2+ modulator of ROS-GC; hence, named recoverin
“because it promotes recovery of the dark state” (Dizhoor et al.,
1991). However, ever purer preparations of recoverin showed a
disturbing decline in guanylate cyclase stimulation. It became evi-
dent that recoverin was not the sought after regulator of guanylate
cyclase activity and the initial conclusion was withdrawn (Hurley
et al., 1993). Instead, recoverin exerted Ca2+-dependent control
over the phosphorylation of photoexcited rhodopsin by rhodopsin
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kinase (Chen et al., 1995; Klenchin et al., 1995; Kawamura, 1999).
At almost the same time, two separate groups discovered sim-
ilar but distinct guanylate cyclase activating proteins (GCAPs),
GCAP1 (Palczewski et al., 1994; Subbaraya et al., 1994; Gorczyca
et al., 1995; Frins et al., 1996) and GCAP2 (Dizhoor et al., 1995).
These GCAPs did indeed stimulate ROS-GC activity as described
by Koch and Stryer (1988).
Recombinant ROS-GC expressed in a heterologous system of
COS cells responded at 10 nM [Ca2+]i to GCAP1 stimulation
in a dose-dependent manner (Duda et al., 1996b). The stimu-
lation was inhibited cooperatively by free Ca2+ with a K1/2 of
100 nM. Under identical conditions, GCAP1 had no effect on
recombinant ANF-RGC, the peptide hormone receptor guanylate
cyclase. An important characteristic of the transduction system
was that GCAP remained bound to ROS-GC at low and high
Ca2+ levels, consistent with physiological observations (Kouta-
los et al., 1995). Similar reconstitution studies established GCAP2
as another Ca2+-sensing subunit of ROS-GC (Dizhoor et al., 1995;
Gorczyca et al., 1995). When a second ROS-GC was subsequently
discovered in the bovine retina, termed Ret-GC2 in human retina
(Lowe et al., 1995), it was named ROS-GC2 to distinguish it from
the original ROS-GC which was renamed as ROS-GC1 (Goracz-
niak et al., 1997). It became clear that a Ca2+-modulated system,
composed of a pair of ROS-GCs and a pair of GCAPs, sub-
serves phototransduction in the outer segments of photoreceptors.
This conclusion was supported at the physiological level by the
studies with the double knockout ROS-GC1/ROS-GC2 mouse
model (Baehr et al., 2007). Rods and cones were non-functional,
excluding the presence of a third guanylate cyclase linked with
phototransduction.
Thus ROS-GCs are related to peptide hormone receptor guany-
late cyclases but they do not respond to extracellular ligands.
Instead, they exist in stable complexes with GCAPs that sense
changes in internal [Ca2+]. The feature that incrementing [Ca2+]i
progressively reduces ROS-GC1 catalytic activity was academically
challenging because such a mechanism had never been observed
before for any of the members of the guanylate cyclase family. All
other members were solely stimulated by their effector ligands,
natriuretic peptide hormones, at their extracellular domains. The
molecular properties of this remarkable system and the role that
the system plays in phototransduction are described in greater
depth in Pugh et al. (1997), Sharma and Duda (2012).
DISCOVERY OF CD-GCAP MEANT THAT ROS-GC1 COULD
OPERATE AS A Ca2+ BIMODAL TRANSDUCTION SWITCH
Contemporaneous with the discovery of GCAPs that stimulated
ROS-GC1 at low Ca2+, a post-mitochondrial 100,000 g super-
natant fraction from retina was found to stimulate recombinant
ROS-GC at high Ca2+ by as much as 25-fold (Pozdnyakov
et al., 1995). The new factor was a peptide with an apparent
molecular weight of 6–7 kDa protein that oligomerized to a
functional size of 40 kDa. It stimulated native and recombi-
nant ROS-GC with a K1/2 for Ca2+ of 2 μM with biochemical
characteristics typical of a Ca2+-binding protein. To distinguish
it from the just-discovered GCAPs, the new factor was named
CD-GCAP (Ca2+-dependent guanylate cyclase activator protein;
Pozdnyakov et al., 1995).
The capacity for ROS-GC to couple to GCAPs or to CD-GCAP
allows for a cell to sculpt its response to Ca2+. Depending upon
the cell’s speciﬁc needs, it could express either GCAP orCD-GCAP
to stimulate cyclic GMP synthesis at low (tens of nanomolar) or at
high (sub-micromolar) ranges of [Ca2+]. An even more exciting
possibility exists for the simultaneous expression of both Ca2+-
regulatory subunits in the same cell. ROS-GC could then operate
as a Ca2+-bimodal transduction switch, stimulated at low and at
high free [Ca2+] by Ca2+ -free GCAPs and by Ca2+-bound S100B,
respectively. A theoretical Ca2+-BIMODAL ROS-GC transduc-
tion model embodying these features was proposed (Figure 1).
Bimodal Ca2+ sensing could be an elegant general mechanism for
neural transmission.
CD-GCAP IS AN S100 PROTEIN
The ﬁrst indication that CD-GCAP might be related to S100
proteins was that it appeared as a 6–7 kDA Ca2+-binding pro-
tein on SDS-PAGE (Pozdnyakov et al., 1995). S100 proteins are
known to run anomalously as 6–7 kDa proteins in SDS-PAGE
even though their subunit molecular weight, calculated from
amino acid (aa) sequence, is about 10.5 kDa (Kligman and Mar-
shak, 1985). Additional evidence for the structural similarity of
CD-GCAP to S100 emerged from mass spectrometry analysis
(Pozdnyakov et al., 1997). The fragmented molecular masses of
10,580 Da for CD-GCAP and 10,582 Da for S100B were essentially
the same. Tryptic digests also yielded indistinguishable fragmen-
tation patterns. Finally, bovine CD-GCAP and bovine S100B
FIGURE 1 | Original theoretical Ca2+ bimodal ROS-GC transduction
model. In the absence of bound Ca2+, GCAPs 1 and 2 boost ROS-GC1
catalytic activity. In contrast, S100B boosts ROS-GC1 activity in the
Ca2+-bound state. GCAPs sense [Ca2+]i < 200 nM while S100B senses
[Ca2+]i > 200 nM.Thus in the GCAPs operational mode the S100B switch
is “OFF” and in the S100B operational mode the GCAP switch is “OFF”
(Upgraded with permission from Sharma, 2010; Sharma and Duda, 2012).
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were cloned and their predicted primary protein structures were
identical (Pozdnyakov et al., 1997).
Despite being structurally identical proteins, biochemical anal-
yses revealed two surprising functional discrepancies. As expected,
S100A1–S100B and S100ββ dimer (S100B) from commercial
sources stimulated cloned recombinant and wt-photoreceptor
ROS-GC (Duda et al., 1996a; Margulis et al., 1996). But the Vmax
of ROS-GC was about 50% higher when activated by CD-GCAP
than when activated by commercially obtained S100B. In addi-
tion, the commercial S100B required about 20-timesmore calcium
(3.2 x 10−5 M vs. 1.5 x 10−6 M for CD-GCAP) for half-maximal
stimulation of guanylate cyclase. Clearly, CD-GCAP was not quite
the same as the commercially obtained S100B.
In the search for the explanation for these functional differ-
ences, the proteins were analyzed for post-translational modi-
ﬁcations and higher order structures (Pozdnyakov et al., 1997).
After treating both proteins with hydroxylamine, a deacylating
agent, CD-GCAP no longer activated guanylate cyclase while
S100B activation retained its ability to do so. Furthermore,
hydroxylamine fragmented CD-GCAP while S100B was unaf-
fected. These results indicated that the conformations of the
two proteins were different. Such a difference could have arisen
from variations in the procedures for purifying the two pro-
teins: CD-GCAP puriﬁcation entailed heating at 75◦C in 5 mM
Ca2+, while S100B puriﬁcation included zinc afﬁnity chromatog-
raphy (commercial sources refused to provide these details but
their references indicated so). To investigate, CD-GCAP was sub-
jected to zinc afﬁnity chromatography (CD-GCAP-to-S100B) and
S100Bwas heated to 75◦C inCa2+ (S100B-to-CD-GCAP).Guany-
late cyclase activation, calcium–sensitivity, and hydroxylamine
lability measurements demonstrated that CD-GCAP-to-S100B
was identical to S100B and that S100B-to-CD-GCAP was iden-
tical to CD-GCAP. Apparently zinc inhibits the native S100B
potency toward stimulation of ROS-GC. An additional ﬁnding
was that S100B monomer is about twice as effective as the dimer
in activating the ROS-GC catalytic activity. Hence, CD-GCAP
and commercially obtained S100B are conformational isomers.
The native form of S100B present in the retinal neurons is
CD-GCAP.
CHARACTERIZATION OF THE S100B BINDING SITE OF
ROS-GC1
Direct interaction between ROS-GC1 and S100B was veriﬁed by
cross-linking experiments with bis-(sulfosuccinimidyl)suberate.
A cross-linked complex, consisting of ROS-GC1 dimer and
S100B, was detected by both ROS-GC1 and S100B antibodies
on Western blots (Duda et al., 2002). Biochemical experiments
with ROS-GC1 deletion constructs localized an interaction of
S100B with the C-terminus of ROS-GC1, aa 731–1054 (Duda
et al., 1996a). An EC50 of 395 nM, measured using surface plas-
mon spectroscopy, was comparable to the EC50 of 800 nM
for stimulation of ROS-GC1 by S100B in a biochemical assay
(Duda et al., 2002).
Since the aa 733–964 segment containing the putative dimeriza-
tion and catalytic domains is highly conserved, the less conserved
aa 965–1054 segment was subjected to further analyses. First,
three ROS-GC1 deletion mutants: 965–1054, 972–1054, and
1016–1054 were analyzed for their responses to S100B. The
ﬁrst mutant was totally unresponsive, the response of the sec-
ond mutant was only ∼25% and that of the third mutant ∼50%
of the wild-type ROS-GC1 response to S100B. Therefore the entire
region aa 965–1054 of ROS-GC1 is important forCa2+-dependent
stimulation by S100B, but the region aa 965–1016 appears to be
the most critical (Duda et al., 2002). Second, overlapping peptides
encompassing this region were screened for their effects on S100B-
dependent stimulation of ROS-GC1 at high Ca2+. Two peptides
covering aa regions 952–991 and 1029–1040 prevented ROS-GC1
stimulation by S100B. Finer analysis revealed that aa 962–981
formed the critical binding site of ROS-GC1 with half-maximal
binding at 198 nM. A 966RIHVNRS972 motif was obligatory, how-
ever, a ﬂanking cluster of four aa residues, R1039RQK1042 formed a
low afﬁnity binding site.While not absolutely required for binding,
the secondary site was an S100B-modulated transduction site that
conferred a twofold increase in maximal activation of ROS-GC1
(Duda et al., 2002).
These studies validated the unique ability of ROS-GC1 to
respond not only to low Ca2+ signals mediated by GCAPs but also
to high Ca2+ signals mediated by S100B. To analyze the possible
interplay of these signals, the aforementioned ROS-GC1 deletion
mutants were analyzed for their responses to GCAP1 (Duda et al.,
2002) and GCAP2 (Duda et al., 2005). At 10 nM Ca2+, activation
of all mutants was identical to that of wild-type ROS-GC1. Thus,
the S100B and GCAP1 regulatory sites of ROS-GC1 are distinct
and do not interfere with one other. This result was not surpris-
ing because the binding site for GCAP1 was previously mapped to
the N-terminal part of the ROS-GC1 cytoplasmic domain (Duda
et al., 1999; Lange et al., 1999).
The case for GCAP2 was not so clear. Initial mapping had
localized the GCAP2 binding site closer to the C-terminus of
ROS-GC1 (Krishnan et al., 1998). In reconstitution experiments
with the ROS-GC1 deletion mutants (the same as used for
mapping the S100B site: vide supra), the 965–1054 mutant
failed to respond to GCAP2, the 972–1045 responded with
Vmax of ∼50% of that of the wild-type ROS-GC1, and the
response of the 1016–1054 mutant matched that of the wild-
type cyclase, indicating that the functional GCAP2-modulated
domain resided within aa 965–1016. Detailed peptide compe-
tition assays narrowed down the GCAP2-modulated site to the
sequence motif Y965-N981 (Duda et al., 2005). As expected, this
site is distinct from the GCAP1 site. It, however, partially over-
laps with the S100B-regulatory site. These results provide a hint
that, when GCAP1 and S100B are co-expressed, a single ROS-
GC1 complex could operate as a bimodal Ca2+ switch. On
the other hand, when GCAP2 and S100B are co-expressed, the
switch might involve separate populations of ROS-GC1 com-
plexes. Furthermore, identiﬁcation of the binding sites for the
Ca2+ sensors disclosed an intriguing topographical feature of
ROS-GC1; GCAP2 and S100B transmit the Ca2+ signals to the
catalytic domain of ROS-GC1 from the C-terminal side while
GCAP1 does so from a more distant location on the N-terminal
side. These intramolecular mechanics are speciﬁc to ROS-GC1
and are different from the peptide hormone receptor subfamily,
where the signal to the catalytic site migrates solely downstream
from a site on the N-terminus located on the opposite side of
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the membrane. A schematic model of the system is depicted in
Figure 2.
ROS-GC2 has an ∼8x lower afﬁnity for S100B and with S100B
bound at high Ca2+, its maximal activation is twofold lower than
that of ROS-GC1. Substitution of aa 731–1053 of ROS-GC1 into
the corresponding region of ROS-GC2 and vice versa reversed the
selectivity (Duda et al., 1998). These results suggest that ROS-GC2
may be an S100B partner of lesser importance than ROS-GC1.
S100B IS EXPRESSED IN CONES BUT NOT IN RODS
Guided by the knowledge that ROS-GC and GCAPs are present
in photoreceptors, including their outer segments where they
serve as critical components of phototransduction (Cuenca et al.,
1998; Kachi et al., 1999; reviewed in Pugh et al., 1997; Koch et al.,
2010; Sharma and Duda, 2012), and that S100B is also present
in photoreceptors (Rambotti et al., 1999; reviewed in: Rambotti
et al., 2002), questions were raised as to whether a ROS-GC1
bimodal Ca2+ -regulated system operates in visual transduction
and whether it is present in both rods and cones. These issues
are being addressed in mouse (e.g., Wen et al., 2012), for which
there exist useful knockouts including S100B−/−, GCAP1−/−,
GCAP2−/−, GCAP1/GCAP2−/−, ROS-GC1−/−.
Afﬁnity puriﬁed S100B antibody recognized on Western blots
of mouse photoreceptors, a protein of molecular weight cor-
responding to S100B. In biochemical assays, guanylate cyclase
activity of mouse ROSmembranes exhibited bimodal Ca2+ switch
behavior; activity decreased as [Ca2+] rose from 10 to 300 nM and
then increased as [Ca2+] began to exceed 300nM.The“inhibitory”
phase of the guanylate cyclase activity was consistent with the loss
of ROS-GC1 activation by GCAPs upon Ca2+ binding to the latter
and the stimulatory phase with Ca2+-induced activation of ROS-
GC1 activity by S100B. The increase in ROS-GC activity at low
[Ca2+] disappeared inROSmembranes fromGCAP1/GCAP2−/−
mice, whereas the increase in ROS-GC activity at high [Ca2+] was
missing in ROS membranes from S100B−/− mice and from ROS-
GC1−/− mice. The signiﬁcance of the result from ROS-GC1−/−
mice will be revealed below. Yet, regulation of ROS-GC1 by S100B
was not functionally linked to phototransduction in rods because
ﬂash responses from wild-type and S100B-KO rods were indis-
tinguishable (Wen et al., 2012). The possibility that S100B might
FIGURE 2 |The modular nature of ROS-GC1. Left Panel. The dashed lines
on the right show the domain boundaries: LS, leader sequence (note: the
leader sequence is absent from the mature protein shown in the right
panel); ExtD, extracellular domain; TM, transmembrane domain; ICD,
intracellular domain. The designated names and the amino acid
residues constituting their boundaries are indicated on the left: JMD,
juxtamembrane domain housing the indicated GCAP1-binding site; KHD,
kinase homology domain; SHD, signaling helix domain; CCD, core catalytic
domain; CTE, C-terminal extension housing the S100B-binding site. It is
noteworthy that the ICD contains all of the functional domains and that
GCAP1 and S100B target sites on opposite sides of the CCD. Right panel.
The GCAP1 and S100B signaling pathways within ROS-GC propagate in
opposite directions. The trajectory of the GCAP1 pathway is shown with
the red dashed arrow. From its origin in the JMD, it passes “downstream”
through the structural KHD and SHD in its course to the CCD. The
trajectory of the S100B pathway shown with the blue dashed arrow.
Originating in the CTE, it directly ﬂows “upstream” to the CCD. The CCD
exists as an antiparallel homodimer. Both GCAP1 and S100B signals are
translated at the CCD into faster production of cyclic GMP (Modiﬁed from
Duda et al., 2012).
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contribute to the rod photoresponse at high free [Ca2+] outside
the normal physiological range was tested and not found.
Detailed histochemical analysis of S100B expression in the
mouse retina brought all these observations into accord (Figure 3).
As expected, the S100B-KO retina showed no S100B immunore-
activity (Wen et al., 2012), afﬁrming the speciﬁcity of the S100B
antibody, because photoreceptor outer segments also express
S100A1, another member of the S100 family (Rambotti et al.,
1999). S100B immunoreactivity was present in wild-type photore-
ceptors, however, it was not present in all of them. The scattered
S100B staining corresponded to that for cone-speciﬁc arrestin. On
the other hand, in retinas of Nrl−/− mice, all outer segments
labeled for S100B as well as for cone arrestin. Because Nrl−/−
retina is rod-less and populated exclusively with cone photorecep-
tors (Mears et al., 2001) these results strongly indicate that among
photoreceptors, S100B expression is restricted to cones. Unimodal
switch behavior in ROS-GC1−/− outer segments (above) is now
easy to understand. In ROS-GC1−/− retinas, cones degenerate but
the rods remain intact (Yang et al., 1999). Rods however, do not
express S100B, so the only Ca2+-regulated guanylate cyclase activ-
ity in ROS-GC1−/− retinas is the GCAPs modulated ROS-GC2
activity.
Our ongoing immunohistochemical studies with the Nile Rat
(Arvicanthis ansorgei) retina in which 33% of the photoreceptors
are cones, in contrast to the 3% cone population in the mouse
(Bobu et al., 2006) appear to corroborate the conclusion derived
from analyses of murine retinas that S100B co-exists with ROS-
GC1 exclusively in the cone outer segments.
At present, the question about the role of theROS-GC1bimodal
switch in cone phototransduction is still unanswered because
cones from S100B−/− mice have yet to be recorded. A model
illustrating some of the difﬁculties in understanding the operation
of the bimodal switch is shown in Figure 4. One issue is that
in darkness (DARK), Ca2+ will not bind to S100B and activate
the switch if [Ca2+]i never exceeds 250 nM. However, the value
of 250 nM for [Ca2+]i in darkness was taken from mouse rods
(Woodruff et al., 2002) because measurements from mouse cones
have not yet been made. Thus the true [Ca2+]i for cones in dark-
ness may be higher. A second issue is that without proper restraint,
operation of the bimodal switch at high [Ca2+]i would ignite
an explosive positive feedback: increased cyclic GMP production,
followed by opening of more cyclic GMP-gated channels, which
then allow a greater inﬂux of Ca2+, etc. Cones could accumu-
late lethal levels of Ca2+ or experience a collapse in ion gradients
(DEPOLARIZATION-S100B Mode). Indeed, genetic mutations
that result in a hyperactive ROS-GC complex cause the photore-
ceptors to degenerate (Olshevskaya et al., 2002; Zägel and Koch,
2014).
THE BIMODAL SWITCH EXISTS AT THE
PHOTORECEPTOR-BIPOLAR CELL SYNAPSE
Immunohistochemical studies also place ROS-GC1, GCAP1 and
S100B in the synaptic layers of the retina (Liu et al., 1994; Cooper
et al., 1995; Duda et al., 2002; Venkataraman et al., 2003). To
test whether the ROS-GC1 transduction system utilizes a Ca2+
bimodal switch at the photoreceptor-bipolar cell synapse (pre-
sumably the cone to bipolar synapse, see Figure 3), bovine retinal
synaptosomes (P1) were prepared and analyzed. Purity of the
preparation was ascertained by Western blotting with rhodopsin
kinase antibody. No immunoreactivity for rhodopsin kinase was
detected, assuring that the preparation was not contaminated with
ROSs, the original residential site of the ROS-GC1. Western blots
werepositive forROS-GC1,GCAP1andS100Bdemonstrating that
indeed the synaptosomal fraction contained all the components
FIGURE 3 | Immunhistochemical localization of S100B to cones in the
murine retina. (A) Cone arrestin in red. Cone outer segment labeling is
overshadowed with by strong labeling of the synapse, nucleus and inner
segment. (B) S100B in green. Selected outer segments are labeled
intensely. Inner segments and synapses are also labeled. (C) Composite
showing that cone arrestin and S100B labeling are restricted to cones.
(D) Bright ﬁeld. OS, outer segments; IS, inner segments; ONL, outer
nuclear layer containing nuclei of rods and cones; OPL, outer plexiform
layer containing synapses of rods and cones. (E) Composite showing
cone synapses at higher magniﬁcation. Overlap (yellow) between arrestin
and S100B is not perfect because the former is a soluble protein
whereas the latter is membrane bound. (F) Section from a different
retina that was doubly labeled for cone arrestin in green and S100B in
red at high magniﬁcation. Conditions were adjusted to optimize the
detection of outer segment labeling Courtesy of A. Pertzev, Salus
University.
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FIGURE 4 |Two modes of ROS-GC1 modulation by [Ca2+]i in cones.
Dark state [left]. At [Ca2+]i ∼250 nM Ca2+ sensors: GCAP1, GCAP2,
S100B are ROS-GC1 bound; GCAP1 and GCAP2 are [Ca2+]i bound;
ROS-GC1 is in the basal state. Cyclic GMP generated keeps a fraction of
CNG channels open allowing an inﬂux of Na+ and Ca2+. In this graphical
simpliﬁcation, GCAP2 and S100B are shown bound to the same ROS-GC
dimer but it is more likely that these two Ca2+ sensors bind separate
dimers. Hyperpolarization-GCAP mode [Top right]. LIGHT triggers activation
of phosphodiesterase and hydrolysis of cyclic GMP. The decrease in cyclic
GMP causes CNG channels to close, preventing inﬂux of Na+ and Ca2+
and hyperpolarizing the outer segment plasma membrane. Extrusion of
Ca2+ by the Na+/Ca2+, K+ exchanger lowers [Ca2+]i from ∼250 nM to
about 25 nM. The decline causes GCAPs to stimulate ROS-GC1.
Depolarization-S100B mode [Bottom right]. [Ca2+]i levels rise when CNG
channels open. With K1/2 of 400 nM, S100B captures Ca2+, triggering
activation of ROS-GC1. Cyclic GMP formed could open many more CNG
channels, greatly increasing the inﬂux of Na+ and Ca2+. [Ca2+]i levels rise
still further because extrusion of Ca2+ through Na+/Ca2+, K+ exchanger
slows as the ion gradients collapse. The cone outer segment may lose the
ability to maintain a membrane potential (Modiﬁed from Wen et al., 2012).
of the ROS-GC1 bimodal system and was suitable for functional
analyses.
Tobephysiologically relevant, the components of theROS-GC1
bimodal system, ROS-GC1, GCAP1 and S100B must reside in
proximity and not, e.g., in different populations of synapto-
somes. Because the Western analyses described above did not
provide information about the proximity of ROS-GC1, GCAP1
andS100Bmolecules, immunohistochemical analyses (Duda et al.,
2002; Venkataraman et al., 2003) and cross-linking experiments
were performed.
Cryosections of bovine retina were doubly labeled with anti-
bodies against GCAP1 or ROS-GC1 and SV2, a synaptic vesicle
protein that strongly stains photoreceptor termini (Buckley and
Kelly, 1985). The results revealed co-expression of ROS-GC1 and
GCAP1 in cone synaptic termini (Venkataraman et al., 2003). Sim-
ilarly, co-localization of ROS-GC1 and S100B was shown (Duda
et al., 2002).
Cross-linking experiments with a non-cleavable imidoester
conﬁrmed the proximity of ROS-GC1 and GCAP1 in the
synaptosomal fraction (Venkataraman et al., 2003). Without the
cross-linker, the ROS-GC1 and GCAP1 antibodies identiﬁed
separate bands at ∼120 kDa and ∼21 kDa, respectively, corre-
sponding to the appropriate monomers. But in presence of the
cross-linker, both GCAP1 and ROS-GC1 antibodies identiﬁed a
common immunoreactive band at ∼250 kDa, the approximate
size for a ROS-GC1 dimer-GCAP1 complex. The results demon-
strated that ROS-GC1 and GCAP1, indeed, resided in proximity.
Because ROS-GC1 resides with GCAP1 in cone synaptic ter-
minals and ROS-GC1 also resides with S100B, it was inferred
that all three components of the bimodal system co-reside in
the photoreceptor synaptic terminals, speciﬁcally cone synaptic
terminals.
Functionality of the ROS-GC1 bimodal switch in the P1 frac-
tion was determined by measuring guanylate cyclase activity at
Ca2+ concentrations ranging from 10 nM to 10 μM. Below
200 nM, Ca2+ elicited a dose-dependent decrease in guanylate
cyclase activity with an “inhibitory” value (IC50) for Ca2+ of
100 nM. But at higher concentrations, ROS-GC activity began
to climb with an EC50 of 0.8 μM. Side by side analysis of photore-
ceptor outer segment and P1 membranes demonstrated that the
cyclic GMP synthetic activities were inhibited identically by free
Ca2+ with an IC50 of 100 nM.
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That GCAP1 was involved in the “inhibitory” phase of
ROS-GC1 activity was conﬁrmed by peptide competition exper-
iments. A sequence motif L503–I522 in ROS-GC1 is critical and
speciﬁc for the cyclase activation by GCAP1 (Lange et al., 1999).
The core motif within this domain consists of D507–R518. Anal-
ysis of the P1 and photoreceptor outer segments membranes
in parallel demonstrated that the incremental concentrations of
the L503–I522 and D507–R518 peptides at 10 nM Ca2+ inhibited
their guanylate cyclase activities with the same dose-dependence.
A control peptide of L503–I522 with a scrambled sequence had
no effect on GCAP-dependent ROS–GC1 activity. Both fractions
showed a reversal of the peptide (D507–R518)-dependent inhibi-
tion upon the addition of an excess of GCAP1 (Venkataraman
et al., 2003). Thus Ca2+ signaling in the synapse region is mod-
ulated by GCAP1 and S100B. GCAP1 has the higher afﬁnity
for Ca2+ and upon binding, lowers ROS-GC1 activity. S100B
captures the high Ca2+ signal and upon binding, stimulates
ROS-GC1.
A ROLE IN SIGNAL PROCESSING IN THE RETINA?
ERG recordings from wild-type and S100B−/− mice provided the
ﬁrst clues as to the physiological signiﬁcance of S100B in retinal
function (Wen et al., 2012). The ERG is a ﬁeld potential across the
retina generated by the electrical activity of all cells, including that
of rods and cones (reviewed in: Peachey and Ball, 2003;Weymouth
and Vingrys, 2008). The corneal negative a-wave, which sums the
photocurrent responses of rods, is normal in the S100B-KO mice
because S100B is not present in rods. The corneal positive b-wave,
generated mainly by ON-bipolar cells, displays slower kinetics in
S100B−/− mice; it peaks later and takes longer to recover. Oscilla-
tory potentials that arise from the activity of inner retinal neurons
are smaller and there are disturbances in their timing. Gaps in our
knowledge about what S100B is doing in the cone outer segment,
the cone synapses and for that matter, in other retinal neurons
preclude any attempt to interpret the changes in the ERG at this
time.
FUTURE DIRECTIONS
The composition and the operational principles of cones and
rods differ in ways that support their specialized visual functions:
extremely high sensitivity in rods, rapid responsiveness over awide
dynamic range in cones. In addition to the GCAPs, S100B serves
as an additional Ca2+ sensor component of ROS-GC1 in cones.
Future tasks will be to decode this signal transduction system at
the molecular and physiological levels, to link it with cone-related
dystrophies and to design therapeutic options. Progress would be
facilitated if several important objectiveswere to bemet. (1)A suit-
able mammalian model with abundant cones needs to be selected.
No such mouse model is available at present. Through genetic
manipulation, development of the rods has been suppressed in
Nrl−/− mice and their retinas are cone-exclusive. But these cones
may not be exact copies of the natural, although biochemically
and physiologically, they appear to be very close (Nikonov et al.,
2005, 2006). One alternative is the Nile rat (A. ansorgei), whose
retina contains about 30% cones in contrast to the 3% population
in the mouse (Bobu et al., 2006). (2) The molecular architec-
ture of the ROS-GC complex needs to be understood. Which
combinations of Ca2+ sensor proteins are possible in the com-
plex? Which actually occur? How are their relative levels within
different cell types regulated? (3) Ca2+-modulated signal trans-
ductionby theROS-GCcomplexneeds tobedeﬁned at amolecular
level. For the S100B native to cones, what are the kinetic param-
eters of the S100B transduction switch? By what mechanism does
S100B sense Ca2+ and how does it effect a change in the cat-
alytic domain of ROS-GC? (4) The physiological role of S100B
in the cone photoresponse needs to be assessed. Does it acceler-
ate the recovery of cone response and increase the dark current?
What limits S100B stimulatedROS-GCactivity at highCa2+? Does
S100B increase the rate of vesicular release of neurotransmitter at
the synapse? S100A1 is also expressed in outer segments, what is
its function? (5) S100B is expressed in inner retinal neurons but
nothing is known about what it does there. (6) S100B protein does
not ﬁt in the presently classiﬁed NCS protein family, sharing only
15% sequence identity and containing only two EF-hands. There-
fore, the NCS family needs to be expanded to include S100B as a
branch.
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